- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Profit warning hammers Fischer stock
Share prices of x-ray vendor Fischer Imaging of Denver took atumble last month after the company announced that it expectedto post disappointing results for its third quarter (end-September).Fischer shares, which had been hovering in the $12-a-share
Share prices of x-ray vendor Fischer Imaging of Denver took atumble last month after the company announced that it expectedto post disappointing results for its third quarter (end-September).Fischer shares, which had been hovering in the $12-a-share rangebefore the announcement, dropped by nearly half and were tradingat under $6 last week.
Fischer said revenues for the quarter are expected to be slightlyhigher, at $20 million compared with $19.1 million in the sameperiod last year. The company's operating earnings will be aboutbreak-even, compared with operating earnings of $1 million inthe third quarter of 1995.
Fischer experienced weaker order rates across its product linesin the third quarter, according to chairman and CEO Morgan Nields.Nields said Fischer would move to cut expenses to counter thelower earnings.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
